SCHMERTZLER MICHAEL 4
4 · PTC THERAPEUTICS, INC. · Filed Dec 18, 2025
Insider Transaction Report
Form 4
SCHMERTZLER MICHAEL
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-16$30.86/sh+24,000$740,640→ 155,266 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-16−24,000→ 0 totalExercise: $30.86Exp: 2026-01-03→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]Currently exercisable.